Summary
Microchip Technology Inc. (MCHP) has entered into privately negotiated exchange agreements to retire a significant portion of its outstanding convertible senior subordinated notes due in 2025, 2027, and 2037. In exchange for approximately $70.4 million principal of 2025 Notes, $100.7 million of 2027 Notes, and $92.5 million of 2037 Notes, Microchip will issue approximately 2.7 million shares of its common stock and pay approximately $266.0 million in cash. This transaction is expected to close around August 17, 2021. The company is not receiving any cash proceeds from these exchanges; rather, it is using existing cash and potentially borrowings under its credit facility to fund the cash portion of the settlement.
Key Highlights
- 1Microchip is exchanging approximately $263.6 million in aggregate principal amount of convertible notes for shares of common stock and cash.
- 2The exchange involves notes maturing in 2025, 2027, and 2037.
- 3Approximately 2.7 million shares of Microchip's common stock will be issued in the exchange.
- 4The company will pay approximately $266.0 million in cash to noteholders.
- 5These transactions are being conducted as private placements, exempt from registration requirements under the Securities Act.
- 6The exchange will reduce outstanding principal amounts of the respective note series, with significant portions remaining outstanding.
- 7The cash portion of the exchange will be funded by existing cash and/or borrowings under the company's credit facility.
Frequently Asked Questions
The primary purpose is to reduce Microchip's outstanding convertible debt by exchanging it for a combination of common stock and cash. This can potentially simplify the capital structure and reduce future interest obligations.
Yes, the issuance of approximately 2.7 million new shares of common stock will result in some dilution to existing shareholders. The exact impact will depend on the total number of shares outstanding at the time of issuance.
Microchip plans to fund the cash component of the exchange transactions using a combination of its existing cash and cash equivalents, and potentially by drawing on its Amended and Restated Credit Agreement.
No, these shares are being issued in private transactions to specific holders of the convertible notes who are believed to be institutional accredited investors or qualified institutional buyers, and are exempt from registration under the Securities Act.